BCLI Live signaler | Maksimer profitt med Getagraph.com

KJøP 121207 min ago

@ $0.370

Utstedt: 9 feb 2024 @ 15:30

Avkastning: 2.57%

Forrige signal: feb 8 - 20:29

Forrige signal: Selg

Avkastning: -6.68 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 20:38):

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases...

Stats
Dagens volum	398 462
Gjennomsnittsvolum	991 593
Markedsverdi	25.94M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-0.0700 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.950
ATR14	$0.00600 (1.56%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Lebovits Chaim	Buy	15 000	Common Stock
2024-04-17	Dagher Ibrahim B.	Buy	0	Common Stock
2024-04-17	Dagher Ibrahim B.	Sell	0	Common Stock
2024-04-17	Dagher Ibrahim B.	Buy	0	Common Stock
2024-04-18	Lebovits Chaim	Buy	115 072	Common Stock

INSIDER POWER
100.00
Last 89 transactions
Buy: 3 045 109 \| Sell: 254 714

Volum Korrelasjon

Lang: -0.24 (neutral)

Kort: -0.58 (weak negative)

Signal:(46.755) Neutral

Brainstorm Cell Korrelasjon

10 Mest positive korrelasjoner
PWFL	0.914
NATR	0.905
APOP	0.893
RAIL	0.892
QADB	0.892
ACTG	0.887
ATOS	0.884
EML	0.884
HEAR	0.883
EFSCP	0.88

10 Mest negative korrelasjoner
RGC	-0.897
TSP	-0.894
ZUMZ	-0.878
RMGC	-0.877
RMRM	-0.876
ORPH	-0.873
RGF	-0.872
ATAK	-0.87
IMRX	-0.869
BTTX	-0.869

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Brainstorm Cell Korrelasjon - Valuta/Råvare

0.52
( weak )

0.60
( weak )

0.00
( neutral )

-0.51
( weak negative )

-0.45
( neutral )

Brainstorm Cell Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-265 000 (0.00 %)
EPS:	$-0.400

FY	2023
Omsetning:	$0
Bruttogevinst:	$-265 000 (0.00 %)
EPS:	$-0.400

FY	2022
Omsetning:	$0
Bruttogevinst:	$-285 000 (0.00 %)
EPS:	$-0.650

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Brainstorm Cell

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.